153 related articles for article (PubMed ID: 25060940)
21. Acquired factor X deficiency in systemic amyloidosis: management of two cases.
Chaudhary P; Wakim J; Khadim H; Karumbaiah KK; Gajra A
Haemophilia; 2013 Nov; 19(6):e375-6. PubMed ID: 24033815
[No Abstract] [Full Text] [Related]
22. Factor X deficiency and systemic amyloidosis.
Glenner GG
N Engl J Med; 1977 Jul; 297(2):108-9. PubMed ID: 405589
[No Abstract] [Full Text] [Related]
23. Recombinant human factor VIIa in the management of amyloid-associated factor X deficiency.
Boggio L; Green D
Br J Haematol; 2001 Mar; 112(4):1074-5. PubMed ID: 11298609
[TBL] [Abstract][Full Text] [Related]
24. Role of individual factor X concentrate pharmacokinetic studies in perioperative management of AL amyloidosis-associated acquired factor X deficiency.
Lewis AR; Peffley N; Klompas AM; Ashrani AA
Transfusion; 2023 Sep; 63(9):1773-1777. PubMed ID: 37427705
[TBL] [Abstract][Full Text] [Related]
25. Coagulopathy in amyloidosis: combined deficiency of factors IX and X.
McPherson RA; Onstad JW; Ugoretz RJ; Wolf PL
Am J Hematol; 1977; 3():225-35. PubMed ID: 602938
[TBL] [Abstract][Full Text] [Related]
26. Acquired, transient factor X (Stuart factor) deficiency in patient with mycoplasma pneumonial infection.
Peuscher FW; van Aken WG; van Mourik JA; Swaak AJ; Sie LH; Statius van Eps LW
Scand J Haematol; 1979 Oct; 23(4):257-64. PubMed ID: 538412
[TBL] [Abstract][Full Text] [Related]
27. Resolution of acquired factor X deficiency with amyloidosis secondary to plasma cell dyscrasia.
Mohri H
Am J Hematol; 2004 Dec; 77(4):421-2. PubMed ID: 15551292
[No Abstract] [Full Text] [Related]
28. Autologous stem cell transplantation in immunoglobulin light chain amyloidosis with factor X deficiency.
Cordes S; Gertz MA; Buadi FK; Lin Y; Lacy MQ; Kapoor P; Kumar SK; McCurdy A; Dispenzieri A; Dingli D; Hayman SR; Hogan WJ; Pruthi RK
Blood Coagul Fibrinolysis; 2016 Jan; 27(1):101-8. PubMed ID: 26218969
[TBL] [Abstract][Full Text] [Related]
29. Evidence of both von Willebrand factor deposition and factor V deposition onto AL amyloid as the cause of a severe bleeding diathesis.
Harrison JS; Frazier SR; McConnell DD; Yasar SJ; Melnyk N; Salaru G
Blood Coagul Fibrinolysis; 2017 Jun; 28(4):342-347. PubMed ID: 27676646
[TBL] [Abstract][Full Text] [Related]
30. Acquired, non-amyloid related factor X deficiency: review of the literature.
Lee G; Duan-Porter W; Metjian AD
Haemophilia; 2012 Sep; 18(5):655-63. PubMed ID: 23437437
[No Abstract] [Full Text] [Related]
31. Successful treatment of systemic amyloidosis with hepatic involvement and factor X deficiency by high dose melphalan chemotherapy and autologous stem cell reinfusion.
Breems DA; Sonneveld P; de Man RA; Leebeek FW
Eur J Haematol; 2004 Mar; 72(3):181-5. PubMed ID: 14962236
[TBL] [Abstract][Full Text] [Related]
32. Acquired isolated factor X deficiency associated with systemic amyloidosis. Case report and review of literature.
Girmann G; Wilker D; Stadie H; Scheurlen PG
Klin Wochenschr; 1980 Sep; 58(17):859-62. PubMed ID: 7442086
[TBL] [Abstract][Full Text] [Related]
33. Papillary thyroid cancer associated with light-chain amyloidosis initially presenting with small-bowel bleeding and protein-losing enteropathy.
Weng MT; Wong JM; Shin SR; Yao M; Wei SC
J Clin Oncol; 2010 Oct; 28(29):e557-9. PubMed ID: 20713869
[No Abstract] [Full Text] [Related]
34. [Neck dissection in cN0 papillary thyroid carcinoma].
Yan DG; Zhang B
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Mar; 47(3):257-60. PubMed ID: 22805036
[No Abstract] [Full Text] [Related]
35. Pre-operative embolisation of the thyroid artery in a patient with a large papillary carcinoma of the thyroid.
Shojaku H; Takakura H; Watanabe Y; Seto H
J Laryngol Otol; 2012 Sep; 126(9):955-9. PubMed ID: 22892223
[TBL] [Abstract][Full Text] [Related]
36. Systemic AL amyloidosis with acquired factor X deficiency: A study of perioperative bleeding risk and treatment outcomes in 60 patients.
Thompson CA; Kyle R; Gertz M; Heit J; Pruthi R; Pardanani A
Am J Hematol; 2010 Mar; 85(3):171-3. PubMed ID: 20052750
[TBL] [Abstract][Full Text] [Related]
37. Spontaneous resolution of acquired factor X deficiency in amyloidosis.
le Quellec A; Sotto A; Ciurana AJ
J Intern Med; 1993 Sep; 234(3):329-30. PubMed ID: 8354985
[TBL] [Abstract][Full Text] [Related]
38. [The clinical significance of serum free light chain in primary systemic amyloidosis].
Zhai YP; Song P; Li F; Liu HN; Yu YP; Zhou XG; Shi P; An ZM; Zhou X; Zhang CN
Zhonghua Nei Ke Za Zhi; 2011 May; 50(5):404-7. PubMed ID: 21624224
[TBL] [Abstract][Full Text] [Related]
39. Noninvasive encapsulated follicular variant of papillary thyroid carcinoma: is lobectomy sufficient for tumours ≥1 cm?
Rosario PW; Penna GC; Calsolari MR
Clin Endocrinol (Oxf); 2014 Oct; 81(4):630-2. PubMed ID: 24350640
[No Abstract] [Full Text] [Related]
40. Mechanism of factor X deficiency in systemic amyloidosis.
Furie B; Voo L; McAdam KP; Furie BC
N Engl J Med; 1981 Apr; 304(14):827-30. PubMed ID: 7207512
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
